Home › Companies › DIANTHUS THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and DIANTHUS THERAPEUTICS INC.’s Form 8-K, filed 2025-05-22 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2024-2025 2025-2026
Explore DIANTHUS THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are DIANTHUS THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-22 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Marino Garcia | 23,703,737 | -- | -- | 2,122,220 | 1,996,674 | Majority: yes |
| Elect Director: Paula Soteropoulos | 22,695,868 | -- | -- | 3,130,089 | 1,996,674 | Majority: yes |
| Proposal 2: Advisory Vote on Executive Compensation The Company's stockholders approved, on an advisory basis, the compensation paid to the Company's named executive officers | 22,132,031 | 3,684,797 | 9,129 | -- | 1,996,674 | Majority: yes |
| Proposal 3: Ratification of Appointment of Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of Deloitte & Touche, LLP as the Company's independent registered public accounting firm for the fiscal year ending Dec | 27,812,736 | 1,706 | 8,189 | -- | -- | Majority: yes |
Source: DIANTHUS THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-05-22 — read the filing on EDGAR.
Each item below shows how the 136 asset managers that disclosed a DIANTHUS THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 7 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
DIANTHUS THERAPEUTICS INC.’s own tally for this item (“Proposal 2: Advisory Vote on Executive Compensation The Company's stockholders approved, on an advisory basis, the compensation paid to the Company's named executive officers”): 22,132,031 for, 3,684,797 against, per its Form 8-K filed 2025-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,125,933 outstanding shares: 69% for, 11% against (80% of the company cast a for/against vote).
The 136 asset managers below cast 86% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 7,035,500 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 2,866,733 | 0 | 0 | 0 | For |
| Fairmount Funds Management LLC | 2,700,691 | 0 | 0 | 0 | For |
| Octagon Capital Advisors LP | 2,341,667 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 2,341,613 | 0 | 0 | 0 | For |
| VR Adviser, LLC | 1,744,373 | 0 | 0 | 0 | For |
| Bain Capital Life Sciences Investors, LLC | 1,689,374 | 0 | 0 | 0 | For |
| TCG Crossover Management, LLC | 1,501,624 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 1,421,047 | 0 | 0 | Against |
| 5AM Venture Management, LLC | 1,027,711 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 0 | 769,639 | 0 | 0 | Against |
| Catalio Capital Management, LP | 535,539 | 0 | 0 | 0 | For |
| Point72 | 0 | 481,235 | 0 | 0 | Against |
| Vanguard | 0 | 448,289 | 0 | 0 | Against |
| Citadel | 441,364 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 381,054 | 0 | 0 | 0 | For |
| Charles Schwab | 337,002 | 0 | 0 | 0 | For |
| BlackRock | 300,068 | 5,282 | 0 | 0 | For |
| GREAT POINT PARTNERS LLC | 275,000 | 0 | 0 | 0 | For |
| State Street | 272,012 | 1,555 | 0 | 0 | For |
| Janus Henderson | 0 | 262,148 | 0 | 0 | Against |
| Candriam S.C.A. | 0 | 248,610 | 0 | 0 | Against |
| Woodline Partners LP | 237,555 | 0 | 0 | 0 | For |
| GV Management Company, L.L.C. | 208,697 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0 | 189,000 | 0 | 0 | Against |
Showing the 25 largest of 136 asset managers. See all 136 in the interactive database.
Combines 2 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
DIANTHUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Marino Garcia”): 23,703,737 for, 2,122,220 withheld, per its Form 8-K filed 2025-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,125,933 outstanding shares: 74% for, 7% withheld (80% of the company cast a for/withheld vote).
The 41 asset managers below cast 100% of the shares they voted on this item FOR (4,500,416 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,982,158 | 0 | 0 | 0 | For |
| AllianceBernstein | 557,585 | 0 | 0 | 0 | For |
| Vanguard | 446,119 | 0 | 0 | 0 | For |
| Charles Schwab | 164,097 | 0 | 0 | 0 | For |
| Principal | 110,364 | 0 | 0 | 0 | For |
| BlackRock | 60,035 | 0 | 0 | 0 | For |
| Northern Trust | 50,573 | 0 | 0 | 0 | For |
| Equitable | 34,718 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 20,363 | 0 | Abstain |
| State Street | 17,492 | 0 | 20 | 0 | For |
| Lincoln Financial | 17,400 | 0 | 0 | 0 | For |
| TIAA | 13,465 | 0 | 0 | 0 | For |
| Pacific Life | 11,737 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,319 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 0 | 8,063 | 0 | Abstain |
| Goldman Sachs | 7,432 | 0 | 0 | 0 | For |
| Global X | 6,523 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 6,432 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 5,324 | 0 | Abstain |
| ProShares | 0 | 0 | 4,757 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 4,375 | 0 | Abstain |
| SEI | 3,900 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 3,559 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 2,686 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 2,342 | 0 | Abstain |
Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.
Combines 2 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
DIANTHUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Paula Soteropoulos”): 22,695,868 for, 3,130,089 withheld, per its Form 8-K filed 2025-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,125,933 outstanding shares: 71% for, 10% withheld (80% of the company cast a for/withheld vote).
The 41 asset managers below cast 100% of the shares they voted on this item FOR (3,757,084 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,982,158 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 0 | 557,585 | 0 | Abstain |
| Vanguard | 446,119 | 0 | 0 | 0 | For |
| Charles Schwab | 164,097 | 0 | 0 | 0 | For |
| Principal | 0 | 0 | 110,364 | 0 | Abstain |
| BlackRock | 60,035 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 50,573 | 0 | Abstain |
| Equitable | 9,908 | 0 | 24,810 | 0 | Abstain |
| American Century | 0 | 0 | 20,363 | 0 | Abstain |
| State Street | 17,492 | 0 | 20 | 0 | For |
| Lincoln Financial | 17,400 | 0 | 0 | 0 | For |
| TIAA | 13,465 | 0 | 0 | 0 | For |
| Pacific Life | 11,737 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,319 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 0 | 8,063 | 0 | Abstain |
| Goldman Sachs | 7,432 | 0 | 0 | 0 | For |
| Global X | 6,523 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 6,432 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 5,324 | 0 | Abstain |
| ProShares | 0 | 0 | 4,757 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 4,375 | 0 | Abstain |
| SEI | 3,900 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 3,559 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 2,686 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 2,342 | 0 | Abstain |
Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.
99.9% Majority: yes · of votes cast
DIANTHUS THERAPEUTICS INC.’s own tally for this item (“Proposal 3: Ratification of Appointment of Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of Deloitte & Touche, LLP as the Company's independent registered public accoun”): 27,812,736 for, 1,706 against, per its Form 8-K filed 2025-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,125,933 outstanding shares: 87% for, 0.1% against (87% of the company cast a for/against vote).
The 41 asset managers below cast 100% of the shares they voted on this item FOR (4,554,064 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,982,158 | 0 | 0 | 0 | For |
| AllianceBernstein | 557,585 | 0 | 0 | 0 | For |
| Vanguard | 446,119 | 0 | 0 | 0 | For |
| Charles Schwab | 164,097 | 0 | 0 | 0 | For |
| Principal | 110,364 | 0 | 0 | 0 | For |
| BlackRock | 60,035 | 0 | 0 | 0 | For |
| Northern Trust | 50,573 | 0 | 0 | 0 | For |
| Equitable | 34,718 | 0 | 0 | 0 | For |
| American Century | 20,363 | 0 | 0 | 0 | For |
| State Street | 17,512 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,400 | 0 | 0 | 0 | For |
| TIAA | 13,465 | 0 | 0 | 0 | For |
| Pacific Life | 11,737 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,319 | 0 | 0 | 0 | For |
| Brighthouse | 1 | 0 | 8,062 | 0 | Abstain |
| Goldman Sachs | 7,432 | 0 | 0 | 0 | For |
| Global X | 6,523 | 0 | 0 | 0 | For |
| John Hancock | 6,432 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 5,324 | 0 | 0 | 0 | For |
| ProShares | 4,757 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 4,375 | 0 | 0 | 0 | For |
| SEI | 3,900 | 0 | 0 | 0 | For |
| DWS | 3,559 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 2,686 | 0 | 0 | 0 | For |
| Calvert | 2,342 | 0 | 0 | 0 | For |
Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.
Ranked by the number of DIANTHUS THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 32,125,933 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 21.90% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 8.92% |
| 3 | Fairmount Funds Management LLC | 8.41% |
| 4 | Octagon Capital Advisors LP | 7.29% |
| 5 | Deep Track Capital, LP | 7.29% |
| 6 | VR Adviser, LLC | 5.43% |
| 7 | Bain Capital Life Sciences Investors, LLC | 5.26% |
| 8 | TCG Crossover Management, LLC | 4.67% |
| 9 | AllianceBernstein | 4.42% |
| 10 | 5AM Venture Management, LLC | 3.20% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| FMR (Fidelity) | 13.95% | 13F |
| Sirenia Capital Management LP | 8.71% | 13G |
| RA Capital Management, L.P. | 8.13% | 13G |
| Wellington Management Group LLP | 8.08% | 13G |
| Fairmount Funds Management LLC | 6.66% | 13D |
| Avidity Partners Management LP | 6.55% | 13D |
| BlackRock | 5.03% | 13F |
| TCG Crossover GP II, LLC | 4.67% | 13G |
| Point72 | 4.63% | 13F |
| BCLS Fund III Investments, LP | 4.10% | 13G |
Percentages above are of 32,125,933 shares outstanding, as reported by DIANTHUS THERAPEUTICS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from DIANTHUS THERAPEUTICS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At DIANTHUS THERAPEUTICS INC.'s shareholder meeting held 2025-05-22, in the 2024-2025 proxy season, 136 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 620 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation paid to our named executive officers; and — FOR was 86% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: DIANTHUS THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-22.
DIANTHUS THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.